New research with Hilterapia

Research: focus on Hilterapia®
To inhibit the growth of two of the main bacteria which cause commonly-contracted infections in hospitals, difficult to eradicate due to their resistance to antibiotics: research highlights the effectiveness of Hilterapia®, thus confirming its value in treating infected wounds. 
The therapy also contributes to concrete solutions in many other fields, such as that of intersection syndrome.
 

CONTINUOUS TRAINING

A DIKTAT FOR MLS® & MAGNETO
ASA’s training program focused on Magnetotherapy Qs and MLS® Laser Therapy continues. From Great Britain to Peru, company staff, supported also by internationally renowned specialists, are in the front line to disseminate the best use of the therapies. The objective: to assist doctors and physiotherapists in their daily activities, concretely acting towards patients recovering their wellbeing.
 

OUTCOMES AND NEW PROSPECTS
Internationalisation and sustainability are the keystones of ASA’s final balance for 2019, marked by a Central and South America performance which has doubled compared with 2018 and by a 20% growth in the Far East.
To be underlined: the consolidation of the veterinary sector, the continuous investment in research and training and the attention paid towards a “Sustainable” business management.
 

THE MOST-READ IN THE BLOG
Nd:YAG Laser and 1064 Diode Laser what are they and what are the differences? An understanding is useful to operate with awareness in the world of Laser Therapy, which is increasingly useful to treat multiple pathologies. 
A salient example is treating hernia pain, both cervical and lumbar.

 

 
Facebook
Twitter
LinkedIn
Instagram
Copyright © 2020, All rights reserved.
ASA srl | Via Galileo Galilei, 23 - 36057 Arcugnano (Vicenza) Italia
T. +39 0444 289200 | marketing@asalaser.com | www.asalaser.com